City of Hope is offering an interactive educational conference for oncologists, hematologists and oncology nurses to learn about the latest advances in bone marrow transplants, as well as the treatment of leukemia, lymphoma and myeloma.
Steven T. Rosen, MD
Almost 150,000 Americans will be diagnosed with a blood cancer this year, highlighting the need for clinicians to stay abreast of current best practices in the treatment of blood cancers. For that purpose, City of Hope is offering an interactive educational conference for oncologists, hematologists and oncology nurses to learn about the latest advances in bone marrow transplants, as well as the treatment of leukemia, lymphoma and myeloma.
“How the Experts Treat Hematologic Malignancies,” an accredited continuing medical education event, will include updates on curative and palliative treatments and evolving molecular and immunology-based system therapies, as well as information on clinical trials.
Over the course of the two-and-a-half-day program, to be held March 10 to 12 at Mandarin Oriental in Las Vegas, participants will review the role and timing of hematologic cell transplant in younger and older patients, discuss new targeted diagnostic therapeutic strategies, summarize the evolving therapeutic strategies for the treatment of hematologic malignancies, and learn how to integrate best practices for prevention, detection and management of side effects related to current therapies.
“City of Hope is in a unique position to provide the medical community with knowledge about leading-edge research and treatment in blood cancers,” said Steven T. Rosen, MD, provost and chief scientific officer at City of Hope, an independent biomedical research institution and cancer treatment center near Los Angeles. “Nearly four decades ago, City of Hope helped pioneer bone marrow transplantation and is now a leader in bone marrow, stem cell and cord blood transplant and immunotherapy.
“Today, our physicians feel a responsibility to share their expertise with the rest of the world in order to improve care for all patients,” said Rosen, the Irell & Manella Cancer Center Director’s Distinguished Chair.
City of Hope is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. More information about the hematologic malignancies conference can be found on City of Hope’s continuing medical education site.
For more information, visit www.cityofhope.org or follow City of Hope on Facebook, Twitter, YouTube or Flickr.
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, California, just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics.